McMaster Perspective

  • Penicillin allergy in the hospital

    Penicillin allergy in the hospital

    McMaster University’s Dr David McCullagh, fellow in infectious disease, and Dr Derek Chu, fellow in clinical immunology and allergy, discuss approaches to patients at risk of penicillin allergy in the acute setting.

  • Steroids in pneumonia and ARDS

    Steroids in pneumonia and ARDS

    Dr Bram Rochwerg, critical care expert and member of the Society of Critical Care Medicine and European Society of Intensive Care Medicine Corticosteroid Guideline Task Force, explains the rationale and evidence behind using steroids in pneumonia and ARDS.

  • Steroids in sepsis

    Steroids in sepsis

    Dr Bram Rochwerg, critical care expert and member of the Society of Critical Care Medicine and European Society of Intensive Care Medicine Corticosteroid Guideline Task Force, discusses updated recommendations on use of steroids in sepsis.

  • Mechanical VTE prophylaxis in critical care. Part 2

    Mechanical VTE prophylaxis in critical care. Part 2

    Dr Yaseen Arabi, chairman of Intensive Care Department at King Abdulaziz Medical City and professor at King Saud bin Abdulaziz University for Health Sciences, explains in detail the surprising findings from his group’s study on mechanical VTE prophylaxis in critical care.

  • Mechanical VTE prophylaxis in critical care. Part 1

    Mechanical VTE prophylaxis in critical care. Part 1

    Dr Yaseen Arabi, chairman of the Intensive Care Department at King Abdulaziz Medical City and professor at King Saud bin Abdulaziz University for Health Sciences, explains the recently published results from a study on pneumatic compression devices in critical care.

  • Should we use ASA in primary prevention?

    Should we use ASA in primary prevention?

    Dr Gordon Guyatt, distinguished professor in the department of Health Research Methods, Evidence, and Impact at McMaster University and one of the founders of EBM, discusses reasons behind using aspirin in primary prevention in light of recent studies.

  • IOTA study. Can oxygen harm your patients? Part 2

    IOTA study. Can oxygen harm your patients? Part 2

    Dr Derek Chu, resident in the Clinical Immunology and Allergy Program at McMaster University and recipient of the 2009 Vanier award from the Canadian Institutes of Health Research (CIHR), discusses implications of the recent IOTA study.

  • IOTA study. Can oxygen harm your patients? Part 1

    IOTA study. Can oxygen harm your patients? Part 1

    Dr Derek Chu, resident in the Clinical Immunology and Allergy Program at McMaster University and recipient of the 2009 Vanier award from the Canadian Institutes of Health Research (CIHR), discusses implications of the recent IOTA study.

  • Evolution of EBM. Part 3: Which guidelines can we trust?

    Evolution of EBM. Part 3: Which guidelines can we trust?

    Dr Gordon Guyatt, distinguished professor at McMaster University and one of the founders of EBM, discusses characteristics of a trustworthy guideline.

  • Evolution of EBM. Part 2: Systematic summaries of evidence as a milestone in the clinical decision-making process

    Evolution of EBM. Part 2: Systematic summaries of evidence as a milestone in the clinical decision-making process

    Dr Gordon Guyatt, distinguished professor in the department of Health Research Methods, Evidence, and Impact at McMaster University and one of the founders of EBM, discusses the role of systematic reviews and meta-analyses in the clinical decision-making process.

82 articles - page 2 of 9

We would love to hear from you

  • Do you have any comments?
  • Have you found a mistake?
  • Would you like to suggest a feature?

We use cookies to ensure you get the best browsing experience on our website. Refer to our Cookies Information and Privacy Policy for more details.